Recent Updates
Recently added Catalysts
DRIO Positive Sentiment Score: 70/100

DarioHealth to Report Fourth Quarter 2022 Results on Thursday, March 9th

Key Takeaway: DarioHealth Corp. announced it will release its financial results for the fourth quarter and year ended December 31, 2022, on March 9, 2023. The company will host a conference call and webcast at 8:30 AM ET, featuring leadership from DarioHealth. This event will provide insights into the company's performance and future outlook in the digital therapeutics space.

Market Sentiment Analysis

POSITIVE FACTORS

  • DarioHealth is a leader in the digital therapeutics market.
  • The upcoming financial results may highlight significant progress.
  • The company provides personalized solutions for chronic condition management.

Full Press Release Details

Company to host conference call and webcast at 8:30 am ET
NEW YORK, March 2, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the fourth quarter and year ended December 31, 2022, on Thursday, March 9, 2023, before market opens and will host a conference call and webcast at 8:30 am Eastern Time.
Erez Raphael, Chief Executive Officer, Rick Anderson, President, and Zvi Ben-David, Chief Financial Officer will host the call.
Conference Call Details
Date: Thursday, March 9, 8:30am ET
Dial-in Number: 1-877-451-6152 (domestic) or 1-201-389-0879 (international)
Participants can use Guest dial-in #s above and be answered by an operator OR click the Call me™ link for instant telephone access to the event. This link will be made active 15 minutes prior to scheduled start time.
Conference title: DarioHealth Corp. - Fourth Quarter 2022 Results Call
Participants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through Sunday, April 9, 2023. To listen to the replay, dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and use replay passcode 13736726.
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Our user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Making the right thing to do the easy thing to do.
Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.
DarioHealth Corporate Contact:
Investor Relations Contact:
SOURCE DarioHealth Corp.

21 %

more press release views with

Frequently Asked Questions

When will DarioHealth announce its Q4 2022 financial results?

DarioHealth will announce its Q4 2022 financial results on March 9, 2023.

What time is the conference call for DarioHealth's financial results?

The conference call is scheduled for 8:30 am ET on March 9, 2023.

How can I access the DarioHealth conference call?

Dial 1-877-451-6152 for domestic or 1-201-389-0879 for international access.

Is there a replay available for the conference call?

Yes, a replay will be available approximately two hours post-call until April 9, 2023.

What services does DarioHealth provide?

DarioHealth offers digital therapeutics for chronic conditions through personalized interventions.

Last updated: Mar 2, 2023